Angelman syndrome is a rare disease that disrupts the normal development and function of cells, particularly in the nervous system, leading to severe developmental delays and learning disabilities.

Concord Biotech Ltd on Thursday said it has invested USD 10 lakh (nearly Rs 85 crore) in US-based Palvella Therapeutics, Inc ...

Several rare immune disorders are caused by mutations in the patient's DNA. A Surrey team and collaborators found that targeting the mutated pathways with new drugs offers new hope for people ...

The Sink family in Sachse hosts 'Do It for Declan' 5K raising awareness and money for research into Sanfilippo syndrome, the ...

As she plays soccer with her mother, Angie, at an Edmonds park, she's asked if she is competitive. "Yes!" Foy responded with ...

Getting Alma, the medical care she needed was hard in their home country of Venezuela which is why her family decided to come to the United States. Today, they are grateful to see healthier changes in ...

Rafael Holdings, Inc. (NYSE: RFL), today reported its financial results for the first quarter of fiscal year 2025 ended October 31, 2024. "We anticipate ...

Avidity Biosciences' AOC platform shows promising results for genetic diseases, making it a strong buy with potential upside ...

Ending the diagnostic journey for patients, particularly those with rare diseases, improves patients' quality of life while ...

India, home to 96 million rare disease patients, is considering eliminating local drug trials to expedite treatments, raising ...

It's called Unici Christmas Padel: a padel tournament to combat Camk2. On Saturday, December 14, from 10:00 AM to around 2:00 ...